New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
06:06 EDTGWPHCNN documentary supports GW's broad approach, says Piper Jaffray
Piper Jaffray believes Sanjay Gupta's CNN special last night entitled "Weed Part 2: Cannabis Madness" further validates GW Pharmaceuticals' broad approach to cannabinoid development. Piper believes GW's manufacturing capabilities and "superior" extraction processes were highlighted on the show. It keeps an Overweight rating on the stock with a $97 price target.
News For GWPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for GWPH

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use